Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cross-Protective IgG and IgA Antibodies against Oncogenic and Non-Oncogenic HPV Genotypes.

Asian Pacific journal of cancer prevention : APJCP - 1 Sept 2020

Costa Ana Paula, Giraldo Paulo César, Cobucci Ricardo Ney, Consolaro Márcia Lopes, Souza Raquel Pantarotto, Canário Luanda Barbara, Machado Paula Renata, Randall Martins Rand, Vieira Baptista Pedro, Jr José Eleutério, Gonçalves Ana Katherine

Abstract excerpt

OBJECTIVE: The aim of the study was to describe the course of IgG/IgA immune response in women immunized with bivalent vaccine and in women non-vaccinated with HPV infection, as well as evaluating the cross-protection against non-vaccine HPV types. METHODS: Serum and cervical mucus samples were collected from infected and vaccinated women for HPV detection/genotyping and for detection of IgG/IgA anti-HPV/VLP...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Viral
Share to Cervix Uteri

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunoglobulin A

Share to Immunoglobulin G

Share to Papillomaviridae

Share to Uterine Cervical Dysplasia

Share to Uterine Cervical Neoplasms

Share to Vaccination

Source

Open in PubMed Open full text

Identifiers

PMID: 32986383
DOI: 10.31557/APJCP.2020.21.9.2799
PMCID: PMC7779425

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cross-Protective IgG and IgA Antibodies against Oncogenic and Non-Oncogenic HPV Genotypes.PMID 32986383Read ↗

HPV vaccine-induced cross-neutralising antibodies target complex epitopes on the major capsid proteinSemantic proximity Read ↗

Human papillomavirus vaccines and the potential for cross-protection between related HPV typesSemantic proximity Read ↗

Human Papillomavirus (HPV) Vaccines: Limited Cross‐Protection against Additional HPV TypesSemantic proximity Read ↗

L2 epitope presenting virus-like particles as broad- spectrum vaccine candidates targeting genus beta human papillomavirusesSemantic proximity Read ↗

Seropositivity to non-vaccine incorporated genotypes induced by the bivalent and quadrivalent HPV vaccines: A systematic review and meta-analysis.Semantic proximity Read ↗

Generation of Monoclonal Antibodies and Development of Sandwich ELISA for 9-valent HPV VaccinesSemantic proximity Read ↗

Relationship between Humoral Immune Responses against HPV16, HPV18, HPV31 and HPV45 in 12-15 Year Old Girls Receiving Cervarix® or Gardasil® Vaccine.Semantic proximity Read ↗

Comparison of the immunogenicity of Cervarix<sup>®</sup>and Gardasil<sup>®</sup>human papillomavirus vaccines for oncogenic non-vaccine serotypes HPV-31, HPV-33, and HPV-45 in HIV-infected adultsSemantic proximity Read ↗

A Chimeric 18L1-45RG1 Virus-Like Particle Vaccine Cross-Protects against Oncogenic Alpha-7 Human Papillomavirus TypesSemantic proximity Read ↗

Bivalent Human Papillomavirus (HPV) Vaccine Effectiveness Correlates With Phylogenetic Distance From HPV Vaccine Types 16 and 18Semantic proximity Read ↗

Serologic response to human papillomavirus genotypes following vaccination: findings from the HITCH cohort study.Semantic proximity Read ↗

Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like ParticlesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.